Table 2. Blood plasma concentrations of putative AD biomarker targets as measured by immunoassay.
Molecule | Healthy Cohort |
AD Cohort |
||||
---|---|---|---|---|---|---|
Concentration | Correlation with age |
Concentration | Correlation with age |
|||
Correlation coefficient (r) | p-value | Correlation coefficient (r) | p-value | |||
Aβ42 | 6.49 ± 1.25 pmol/L | 0.0755 | 0.6432 | 6.32 ± 1.74 pmol/L | 0.3802 | 0.0185* |
ApoE | 4776 ± 3238 ng/ml | −0.3833 | 0.0025** | 4607 ± 2689 ng/ml | 0.1369 | 0.3056 |
Clusterin | 2534 ± 1397 ng/ml | −0.2536 | 0.0505 | 2516 ± 1336 ng/ml | 0.0824 | 0.5386 |
Fibrinogen | 49.59 ± 20.72 μg/ml | 0.0570 | 0.6652 | 41.57 ± 21.72 μg/ml | 0.2234 | 0.0918 |
Keratin 9 | 34.7 ± 47.6 pg/ml | −0.2316 | 0.0750 | 64.4 ± 88.0 pg/ml | 0.1646 | 0.2168 |
SPARCL1 | 1126 ± 533 ng/ml | 0.4619 | 0.0002*** | 1204 ± 757 ng/ml | 0.1711 | 0.1992 |
Tau | 43.90 ± 13.78 ng/ml | −0.4082 | 0.0012** | 43.10 ± 14.84 ng/ml | 0.1062 | 0.4275 |
Spearman correlation coefficients for protein concentration and patient age were determined using GraphPad Prism Version 5.02. A p-value ≤ 0.05 was considered statistically significant.